Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Saara Metso

Showing results (31-40 of 54) with videos related to

Pageof 6
Sort By:
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|April 22, 2026
Biological Medicines, Biosimilars and Their Automatic Substitution: Concerns, Knowledge and Information Needs of People with DiabetesMarianne Kouhia, Kari Linden, Saara Metso, et al.
Metabolism: Clinical and Experimental|July 29, 2004
Dietary composition as a determinant of plasma asymmetric dimethylarginine in subjects with mild hypercholesterolemiaHannu Päivä, Terho Lehtimäki, Juha Laakso, et al.
Acta Oncologica (Stockholm, Sweden)|November 19, 2025
Five-year follow-up of patients with low-risk papillary thyroid cancer treated without postoperative radioiodine: prospective study by the Finnish Thyroid Cancer GroupPäivi Halonen, Miika Salo, Veera Ahtiainen, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|April 22, 2006
Plasma asymmetric dimethylarginine (ADMA), nitrate and the indices of low-density lipoprotein oxidationHannu Päivä, Juha Laakso, Inkeri Ruokonen, et al.
Clinical Endocrinology|November 21, 2017
Long-term cardiovascular morbidity and mortality in patients treated for differentiated thyroid cancerNelli Pajamäki, Saara Metso, Tommi Hakala, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|July 1, 2016
HuR in pheochromocytomas and paragangliomas - overexpression in verified malignant tumorsHelena Leijon, Kaisa Salmenkivi, Ilkka Heiskanen, et al.
Journal of the American Geriatrics Society|September 3, 2005
Interleukin-6 modulates plasma cholesterol and C-reactive protein concentrations in nonagenariansTerho Lehtimäki, Petri Ojala, Riikka Rontu, et al.
Endocrine|June 13, 2022
Thymic neuroendocrine tumors in patients with multiple endocrine neoplasia type 1Iina Yliaska, Heikki Tokola, Tapani Ebeling, et al.
Clinical Endocrinology|September 25, 2020
Long-term health-related quality of life in persons diagnosed with an insulinoma in Finland 1980-2010Elina Peltola, Päivi Hannula, Heini Huhtala, et al.
European Journal of Endocrinology|August 10, 2021
Long-term morbidity and mortality in patients diagnosed with an insulinomaElina Peltola, Päivi Hannula, Heini Huhtala, et al.
Pageof 6

Showing results (31-40 of 54) with videos related to

Sort By:
Pageof 6
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|April 22, 2026
Biological Medicines, Biosimilars and Their Automatic Substitution: Concerns, Knowledge and Information Needs of People with DiabetesMarianne Kouhia, Kari Linden, Saara Metso, et al.
Metabolism: Clinical and Experimental|July 29, 2004
Dietary composition as a determinant of plasma asymmetric dimethylarginine in subjects with mild hypercholesterolemiaHannu Päivä, Terho Lehtimäki, Juha Laakso, et al.
Acta Oncologica (Stockholm, Sweden)|November 19, 2025
Five-year follow-up of patients with low-risk papillary thyroid cancer treated without postoperative radioiodine: prospective study by the Finnish Thyroid Cancer GroupPäivi Halonen, Miika Salo, Veera Ahtiainen, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|April 22, 2006
Plasma asymmetric dimethylarginine (ADMA), nitrate and the indices of low-density lipoprotein oxidationHannu Päivä, Juha Laakso, Inkeri Ruokonen, et al.
Clinical Endocrinology|November 21, 2017
Long-term cardiovascular morbidity and mortality in patients treated for differentiated thyroid cancerNelli Pajamäki, Saara Metso, Tommi Hakala, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|July 1, 2016
HuR in pheochromocytomas and paragangliomas - overexpression in verified malignant tumorsHelena Leijon, Kaisa Salmenkivi, Ilkka Heiskanen, et al.
Journal of the American Geriatrics Society|September 3, 2005
Interleukin-6 modulates plasma cholesterol and C-reactive protein concentrations in nonagenariansTerho Lehtimäki, Petri Ojala, Riikka Rontu, et al.
Endocrine|June 13, 2022
Thymic neuroendocrine tumors in patients with multiple endocrine neoplasia type 1Iina Yliaska, Heikki Tokola, Tapani Ebeling, et al.
Clinical Endocrinology|September 25, 2020
Long-term health-related quality of life in persons diagnosed with an insulinoma in Finland 1980-2010Elina Peltola, Päivi Hannula, Heini Huhtala, et al.
European Journal of Endocrinology|August 10, 2021
Long-term morbidity and mortality in patients diagnosed with an insulinomaElina Peltola, Päivi Hannula, Heini Huhtala, et al.
Pageof 6